OncoSec Medical Inc Коэффициент "короткого" интереса
Что обозначает Коэффициент "короткого" интереса в OncoSec Medical Inc?
Коэффициент "короткого" интереса OncoSec Medical Inc является 0.32
Какое определение для Коэффициент "короткого" интереса?
Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Коэффициент "короткого" интереса компаний в Health Care сектор на NASDAQ по сравнению с OncoSec Medical Inc
Что делает OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Компании с коэффициент "короткого" интереса похож на OncoSec Medical Inc
- Yangtze River Port and Logistics Ltd имеет Коэффициент "короткого" интереса из 0.31
- Jupai Ltd имеет Коэффициент "короткого" интереса из 0.31
- TORC Oil & Gas имеет Коэффициент "короткого" интереса из 0.31
- Zhangmen Education имеет Коэффициент "короткого" интереса из 0.31
- Nicola Mining имеет Коэффициент "короткого" интереса из 0.31
- Invesco Municipal Opportunity Trust имеет Коэффициент "короткого" интереса из 0.31
- OncoSec Medical Inc имеет Коэффициент "короткого" интереса из 0.32
- Last Mile имеет Коэффициент "короткого" интереса из 0.33
- Bitcoin Well Inc имеет Коэффициент "короткого" интереса из 0.33
- Euro Manganese имеет Коэффициент "короткого" интереса из 0.33
- Quebec Precious Metals имеет Коэффициент "короткого" интереса из 0.33
- Collective Growth имеет Коэффициент "короткого" интереса из 0.33
- FRNT имеет Коэффициент "короткого" интереса из 0.33